ATMEKSI
NDC 69528-701, methocarbamol, suspension, from Rosemont Pharmaceuticals LLC.
- Product NDC
- 69528-701
- Status
- Listed
- Labeler
- Rosemont Pharmaceuticals LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219843
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69528-701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOCARBAMOL750 mg/5mL
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69528-701-05 | 69528070105 | 150 mL in 1 BOTTLE (69528-701-05) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/62de7345-613b-4838-96e5-aceca3cea6b2
Use it
Look up 69528-701 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69528-701 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69528-701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.